Literature DB >> 31194886

Phosphorylation in two discrete tau domains regulates a stepwise process leading to postsynaptic dysfunction.

Peter J Teravskis1,2, Breeta R Oxnard3, Eric C Miller4, Lisa Kemper5, Karen H Ashe5,6,7, Dezhi Liao1.   

Abstract

KEY POINTS: Tau mislocalization to dendritic spines and associated postsynaptic deficits are mediated through different and non-overlapping phosphorylation sites. Tau mislocalization to dendritic spines depends upon the phosphorylation of either Ser396 or Ser404 in the C-terminus. Postsynaptic dysfunction instead depends upon the phosphorylation of at least one of five residues in the proline-rich region of tau. The blockade of both glycogen synthetase kinase 3β and cyclin-dependent kinase 5 is required to prevent P301L-induced tau mislocalization to dendritic spines, supporting redundant pathways that control tau mislocalization to spines. ABSTRACT: Tau protein consists of an N-terminal projection domain, a microtubule-binding domain and a C-terminal domain. In neurodegenerative diseases, including Alzheimer's disease and frontotemporal dementia, the hyperphosphorylation of tau changes its shape, binding partners and resulting function. An early consequence of tau phosphorylation by proline-directed kinases is postsynaptic dysfunction associated with the mislocalization of tau to dendritic spines. The specific phosphorylation sites leading to these abnormalities have not been elucidated. Here, using imaging and electrophysiological techniques to study cultured rat hippocampal neurons, we show that postsynaptic dysfunction results from a sequential process involving differential phosphorylation in the N-terminal and C-terminal domains. First, tau mislocalizes to dendritic spines, in a manner that depends upon the phosphorylation of either Ser396 or Ser404 in the C-terminal domain. The blockade of both glycogen synthetase kinase 3β and cyclin-dependent kinase 5 prevents tau mislocalization to dendritic spines. Second, a reduction of functional AMPA receptors depends upon the phosphorylation of at least one of five residues (Ser202, Thr205, Thr212, Thr217 and Thr231) in the proline-rich region of the N-terminal domain. This is the first report of differential phosphorylation in distinct tau domains governing separate, but linked, steps leading to synaptic dysfunction.
© 2019 The Authors. The Journal of Physiology © 2019 The Physiological Society.

Entities:  

Keywords:  AMPA Receptors; Alzheimer's Disease; Dendritic Spines; Phosphorylation; Postsynaptic Dysfunction; Tau

Mesh:

Substances:

Year:  2019        PMID: 31194886      PMCID: PMC6908773          DOI: 10.1113/JP277459

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  46 in total

1.  Temporal dynamics of NMDA receptor-induced changes in spine morphology and AMPA receptor recruitment to spines.

Authors:  Hang Lin; Richard Huganir; Dezhi Liao
Journal:  Biochem Biophys Res Commun       Date:  2004-04-02       Impact factor: 3.575

Review 2.  Clinical features of repetitive traumatic brain injury and chronic traumatic encephalopathy.

Authors:  Philip H Montenigro; Charles Bernick; Robert C Cantu
Journal:  Brain Pathol       Date:  2015-05       Impact factor: 6.508

3.  AMPA receptor subunit GluR1 (GluA1) serine-845 site is involved in synaptic depression but not in spine shrinkage associated with chemical long-term depression.

Authors:  Kaiwen He; Angela Lee; Lihua Song; Patrick O Kanold; Hey-Kyoung Lee
Journal:  J Neurophysiol       Date:  2011-02-09       Impact factor: 2.714

4.  SIL1 Rescued Bip Elevation-Related Tau Hyperphosphorylation in ER Stress.

Authors:  Zan-Chao Liu; Jiang Chu; Li Lin; Jie Song; Lin-Na Ning; Hong-Bin Luo; Shu-Sheng Yang; Yan Shi; Qun Wang; Na Qu; Qi Zhang; Jian-Zhi Wang; Qing Tian
Journal:  Mol Neurobiol       Date:  2015-01-10       Impact factor: 5.590

5.  The endogenous and cell cycle-dependent phosphorylation of tau protein in living cells: implications for Alzheimer's disease.

Authors:  S Illenberger; Q Zheng-Fischhöfer; U Preuss; K Stamer; K Baumann; B Trinczek; J Biernat; R Godemann; E M Mandelkow; E Mandelkow
Journal:  Mol Biol Cell       Date:  1998-06       Impact factor: 4.138

Review 6.  Lost after translation: missorting of Tau protein and consequences for Alzheimer disease.

Authors:  Hans Zempel; Eckhard Mandelkow
Journal:  Trends Neurosci       Date:  2014-09-12       Impact factor: 13.837

7.  Axonal disruption and aberrant localization of tau protein characterize the neuropil pathology of Alzheimer's disease.

Authors:  N W Kowall; K S Kosik
Journal:  Ann Neurol       Date:  1987-11       Impact factor: 10.422

Review 8.  Invited review: Frontotemporal dementia caused by microtubule-associated protein tau gene (MAPT) mutations: a chameleon for neuropathology and neuroimaging.

Authors:  B Ghetti; A L Oblak; B F Boeve; K A Johnson; B C Dickerson; M Goedert
Journal:  Neuropathol Appl Neurobiol       Date:  2015-02       Impact factor: 8.090

Review 9.  Protein phosphorylation in neurodegeneration: friend or foe?

Authors:  Sandra Tenreiro; Katrin Eckermann; Tiago F Outeiro
Journal:  Front Mol Neurosci       Date:  2014-05-13       Impact factor: 5.639

10.  Tau association with synaptic vesicles causes presynaptic dysfunction.

Authors:  Lujia Zhou; Joseph McInnes; Keimpe Wierda; Matthew Holt; Abigail G Herrmann; Rosemary J Jackson; Yu-Chun Wang; Jef Swerts; Jelle Beyens; Katarzyna Miskiewicz; Sven Vilain; Ilse Dewachter; Diederik Moechars; Bart De Strooper; Tara L Spires-Jones; Joris De Wit; Patrik Verstreken
Journal:  Nat Commun       Date:  2017-05-11       Impact factor: 14.919

View more
  10 in total

1.  Mechanical injuries of neurons induce tau mislocalization to dendritic spines and tau-dependent synaptic dysfunction.

Authors:  Nicholas J Braun; Katherine R Yao; Patrick W Alford; Dezhi Liao
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-02       Impact factor: 11.205

2.  Developmental Pathogenicity of 4-Repeat Human Tau Is Lost with the P301L Mutation in Genetically Matched Tau-Transgenic Mice.

Authors:  Julia E Gamache; Lisa Kemper; Elizabeth Steuer; Kailee Leinonen-Wright; Jessica M Choquette; Chris Hlynialuk; Kellie Benzow; Keith A Vossel; Weiming Xia; Michael D Koob; Karen H Ashe
Journal:  J Neurosci       Date:  2019-11-04       Impact factor: 6.167

3.  Blocking Site-Specific Cleavage of Human Tau Delays Progression of Disease-Related Phenotypes in Genetically Matched Tau-Transgenic Mice Modeling Frontotemporal Dementia.

Authors:  Elizabeth L Steuer; Lisa J Kemper; Chris J W Hlynialuk; Kailee Leinonen-Wright; Michelle L Montonye; Ian P Lapcinski; Colleen L Forster; Karen H Ashe; Peng Liu
Journal:  J Neurosci       Date:  2022-05-04       Impact factor: 6.709

Review 4.  Tau Acts in Concert With Kinase/Phosphatase Underlying Synaptic Dysfunction.

Authors:  Xing Fan; Liye Xia; Zheng Zhou; Yanyan Qiu; Chenhao Zhao; Xiaomin Yin; Wei Qian
Journal:  Front Aging Neurosci       Date:  2022-05-27       Impact factor: 5.702

5.  Fyn depletion ameliorates tauP301L-induced neuropathology.

Authors:  Guanghao Liu; Kimberly L Fiock; Yona Levites; Todd E Golde; Marco M Hefti; Gloria Lee
Journal:  Acta Neuropathol Commun       Date:  2020-07-14       Impact factor: 7.801

6.  The molecular implications of a caspase-2-mediated site-specific tau cleavage in tauopathies.

Authors:  Peng Liu; Karen H Ashe
Journal:  Neural Regen Res       Date:  2021-09       Impact factor: 5.135

Review 7.  What's in a Gene? The Outstanding Diversity of MAPT.

Authors:  Daniel Ruiz-Gabarre; Almudena Carnero-Espejo; Jesús Ávila; Vega García-Escudero
Journal:  Cells       Date:  2022-03-01       Impact factor: 6.600

Review 8.  NMDA and AMPA Receptors at Synapses: Novel Targets for Tau and α-Synuclein Proteinopathies.

Authors:  Maria Italia; Elena Ferrari; Monica Diluca; Fabrizio Gardoni
Journal:  Biomedicines       Date:  2022-06-29

9.  Orientation of neurites influences severity of mechanically induced tau pathology.

Authors:  Nicholas J Braun; Dezhi Liao; Patrick W Alford
Journal:  Biophys J       Date:  2021-07-20       Impact factor: 3.699

Review 10.  Proteotoxicity and Neurodegenerative Diseases.

Authors:  Clara Ruz; Jose Luis Alcantud; Francisco Vives Montero; Raquel Duran; Sara Bandres-Ciga
Journal:  Int J Mol Sci       Date:  2020-08-06       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.